A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more Americans to give them a try, but the cost may still be too high to keep ...

In addition, those who used antidepressants long-term were twice as likely to become obese as those who didn’t use them. The ...

The White House’s weight-loss drug briefing was halted after Novo Nordisk executive Gordon Findlay fainted on camera, ...

President Donald Trump has long pushed to cut the price of GLP-1 medications, often expressing frustration about the high ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Classic signs of jaw clenching include facial soreness and stiffness, headaches, neck tension, and clicking or limited ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

A recent Kaiser Family Foundation Health Tracking Poll found one-in-eight U.S. adults, or 12 percent of the U.S. population, have said they took a GLP-1 agonist at one point. Sixty-two percent of ...

The CBP chief had originally claimed that Bovino deployed tear gas canisters after he was hit in the head by a rock, but in ...

President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their ...